Eventide Asset Management - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 268 filers reported holding IMMUNOGEN INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$20,631,000
-15.9%
1,300,0000.0%0.37%
-10.6%
Q2 2023$24,531,000
+415.4%
1,300,000
+30.0%
0.42%
+453.3%
Q1 2022$4,760,000
-35.8%
1,000,0000.0%0.08%
-21.1%
Q4 2021$7,420,0001,000,0000.10%
Other shareholders
IMMUNOGEN INC shareholders Q2 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders